Ladenburg Thalmann Financial Services’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-43
Closed 5556
2018
Q3
$0 Hold
43
﹤0.01% 5576
2018
Q2
$0 Hold
43
﹤0.01% 5235
2018
Q1
$0 Hold
43
﹤0.01% 5363
2017
Q4
$0 Hold
43
﹤0.01% 5284
2017
Q3
$0 Hold
43
﹤0.01% 5200
2017
Q2
$0 Hold
43
﹤0.01% 5143
2017
Q1
$0 Hold
43
﹤0.01% 5149
2016
Q4
$0 Hold
43
﹤0.01% 5122
2016
Q3
$0 Hold
43
﹤0.01% 5065
2016
Q2
$0 Hold
43
﹤0.01% 5044
2016
Q1
$0 Hold
43
﹤0.01% 5042
2015
Q4
$0 Hold
43
﹤0.01% 4991
2015
Q3
$0 Hold
43
﹤0.01% 4963
2015
Q2
$0 Hold
43
﹤0.01% 4935
2015
Q1
$0 Buy
+43
New +$136 ﹤0.01% 4832

Other funds holding CELGZ

Ladenburg Thalmann Financial Services's CELGZ Position: Q4 2018 in Review

Ladenburg Thalmann Financial Services sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2018, closing a stake of 43 shares.

Ladenburg Thalmann Financial Services first reported a position in CELGZ in Q1 2015 and held it in 15 quarters. The position peaked at $0 in Q3 2018. 21 funds tracked by Wall St. Rank hold CELGZ as of Q4 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 43 Celgene Corporation Contingent Value Rights shares in Q4 2018.
  • Ladenburg Thalmann Financial Services first reported a position in Celgene Corporation Contingent Value Rights in Q1 2015 and held it in 15 quarters.
  • Ladenburg Thalmann Financial Services's Celgene Corporation Contingent Value Rights position peaked at $0 in Q3 2018.
  • 21 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2018, filed 14 Feb 2019.